We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Adamas Finance Asia Limited | LSE:ADAM | London | Ordinary Share | VGG008271246 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.50 | 23.00 | 26.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMADAM
RNS Number : 8250Q
Adamas Finance Asia Limited
15 September 2017
ADAMAS FINANCE ASIA LIMITED
(the "Company", "ADAM" or the "Group")
DISPOSAL OF INTEREST IN GLOBAL PHARM
Adamas Finance Asia Limited, a London quoted pan-Asian diversified investment vehicle, is pleased to announce the disposal of the Group's interest in Global Pharm Holdings Group Inc. ("Global Pharm") (the "Transaction"). The Transaction is in line with the Company's objective of maximising shareholder returns through a managed disposal programme of its legacy portfolio where commercially viable and reinvesting the proceeds in pan-Asian income producing assets with capital gain potential.
Terms of the Transaction
On 15 September 2017 (the "Signing Date"), the Company entered into a sale and purchase agreement with Fortune Insight Limited ("Fortune") (the "SPA") for the sale of its 75% interest in Blazer Delight Limited ("Blazer Delight"), through which ADAM holds its interest in Global Pharm (the "Global Pharm Interest") for US$15.6 million in cash, which is payable by Fortune within 120 days of the Signing Date.
The Group's interest in Global Pharm was transferred to Fortune on the Signing Date. In the event that Fortune does not meet its payment obligations under the SPA, Fortune will transfer the Global Pharm Interest back to ADAM for nil consideration.
Global Pharm Interest
In February 2014 as part of a reverse takeover, the Group acquired a 75% interest in Blazer Delight, which was a special purpose vehicle holding a convertible bond issued by Global Pharm. At that time, the Global Pharm Interest was independently valued at US$22.4 million (net to ADAM). The Company has received payments of approximately US$6.0 million since the acquisition of the interest which is now being sold for US$15.6 million.
In the Company's audited accounts for the year ended 31 December 2016, the carrying value of the Global Pharm Interest was valued at US$17.3 million. As the negotiated sale price for the Global Pharm Interest is below the Company's current carrying value, completion of the Transaction will result in an accounting loss of US$1.7 million which will be recognised in the results for the six months ended 30 June 2017.
Related party transaction
Fortune is managed by affiliates of Adamas Asset Management (HK) Limited ("AAM"). The Company's largest shareholder, Elypsis Solutions Limited, is also managed by affiliates of AAM and therefore the Transaction is classified as a related party transaction under the AIM Rules for Companies.
The Directors, having consulted with WH Ireland Limited, the Company's nominated adviser, consider that the terms of the Transaction are fair and reasonable insofar as shareholders are concerned.
Suresh Withana of Harmony Capital, the recently appointed Investment Manager to ADAM, stated:
"We are pleased to have achieved the sale of the Global Pharm Interest, which is in line with our objective of exiting the Company's legacy assets where commercially viable and reinvesting the proceeds in pan-Asian income producing assets with capital growth potential. Although the sale is at a loss, the long-term beneficial impact to the Company from the sale of this investment, should be significant."
Enquiries:
Adamas Finance Asia Limited John Croft +44 (0) 1825 830587 WH Ireland Limited - Nominated Adviser +44 (0) 113 394 6600 Tim Feather +44 (0) 117 945 Ed Allsopp 3444 finnCap Limited - Broker William Marle +44 (0) 20 7220 Grant Bergman 0500 Buchanan - Financial PR Charles Ryland Victoria Hayns +44 (0) 20 7466 Henry Wilson 5000
About Adamas Finance Asia
ADAM is a London quoted investment company focusing on delivering long-term income and capital growth to shareholders through a diverse portfolio of pan-Asian investments.
ADAM aims to provide uncorrelated returns through a combination of capital growth and dividend income from a broad spectrum of national geographies and asset classes.
The Company's recently appointed investment manager Harmony Capital, which has a dedicated team with real Asian expertise, will focus on the strategy of creating income and capital growth as well as addressing the issues of the ongoing legacy portfolio. Harmony is sourcing predominately private opportunities and a strong pipeline already exists. Income generating assets include investments in property, mining, pharmaceuticals, and telecoms across Asia.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DISKZLFFDKFZBBZ
(END) Dow Jones Newswires
September 15, 2017 02:00 ET (06:00 GMT)
1 Year Adamas Finance Asia Chart |
1 Month Adamas Finance Asia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions